MaaT013

MaaT013 is a comprehensive, ready-to-use enema therapy that utilizes a standardized mixture of donor microbes belonging to the MET-N (native) donor-derived platform. The formulation of MaaT013 includes a diverse range of gut microbiota sourced from healthy donors, enriched with specific butyrate-producing genera (Butycore TM group), which is recognized for its production of anti-inflammatory metabolites. The primary goal of MaaT013 is to reestablish the symbiotic relationship between the gut microbiome and the immune system, which may lead to improved immune function responsiveness and tolerance.
Source: Company information

see also:
Fecal Microbiota Transplantation (FMT)
MaaT Pharma
Microbiome Ecosystem Therapies (MET) TM